Sunday, September 24, 2023
As organizations accredited by the ACCME, Albert Einstein College of Medicine-Montefiore Medical Center (EINSTEIN) and Medscape, LLC, require everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any ineligible entity (industry). The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months prior to the activity that could create a conflict of interest.
EINSTEIN and Medscape, LLC, encourage Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Medicine
David Geffen School of Medicine
Director of the Pulmonary Vascular Disease Program
UCLA Medical Center
Los Angeles, California
Clinical Professor, Family Medicine
Director, UC Irvine Program in Medical Education for the Latino Community (PRIME-LC)
Associate Dean for Diversity and Inclusion
University of California, Irvine
Irvine, California
None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
This activity has been peer reviewed in its entirety, for bias and objectivity, by reviewers that have no relevant financial relationships in the last 24 months, prior to the activity. The authors of this activity provided educational content and resources in advance, as we requested. All their recommendations for patient care were made based on current science, evidence, and clinical reasoning, while giving a fair and balanced view of unbiased diagnostic and therapeutic options.
Sandhya Murthy, MD has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
Kathleen DiPalo, PharmD has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
Kathleen O’Connor, BSN has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
Victor Hatcher, PhD has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Mitigation
All of the relevant financial relationships listed for these individuals have been mitigated.
This activity is intended for cardiologists, pulmonologists, primary care physicians, nurses, nurse practitioners, physician assistants, and pharmacists.
The goal of this activity is to inform providers of effective strategies to address health disparities in the setting of pulmonary arterial hypertension (PAH)
Upon completion of this activity, participants will:
As organizations accredited by the ACCME, Albert Einstein College of Medicine-Montefiore Medical Center (EINSTEIN) and Medscape, LLC, require everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any ineligible entity (industry). The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months prior to the activity that could create a conflict of interest.
EINSTEIN and Medscape, LLC, encourage Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Medicine
David Geffen School of Medicine
Director of the Pulmonary Vascular Disease Program
UCLA Medical Center
Los Angeles, California
Clinical Professor, Family Medicine
Director, UC Irvine Program in Medical Education for the Latino Community (PRIME-LC)
Associate Dean for Diversity and Inclusion
University of California, Irvine
Irvine, California
None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
This activity has been peer reviewed in its entirety, for bias and objectivity, by reviewers that have no relevant financial relationships in the last 24 months, prior to the activity. The authors of this activity provided educational content and resources in advance, as we requested. All their recommendations for patient care were made based on current science, evidence, and clinical reasoning, while giving a fair and balanced view of unbiased diagnostic and therapeutic options.
Sandhya Murthy, MD has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
Kathleen DiPalo, PharmD has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
Kathleen O’Connor, BSN has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
Victor Hatcher, PhD has disclosed no relevant financial disclosure in the past 24 months with any ineligible company
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Mitigation
All of the relevant financial relationships listed for these individuals have been mitigated.
Presented through a collaboration among Albert Einstein College of Medicine, Montefiore Medical Center, and Medscape Education.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is awarded 0.25 contact hours (based on 60 minutes per contact hour).
This knowledge-based activity UAN # JA4008224-0000-21-056-H01-P qualifies for 0.25 contact hours (0.0025 CEUs) of continuing pharmacy
PLEASE NOTE
For submission of Pharmacist CE credit to CPE Monitor, please ensure your Medscape registration is PROVIDED with your birthdate (MM/DD) and NABP ID number.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
Certificates of completion are not accepted by the ACPE.
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit(s)™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 2/3/2022
Valid for credit through: 2/3/2023, 11:59 PM EST
processing....
The goal of this activity is to inform providers of effective strategies to address health disparities in the setting of pulmonary arterial hypertension.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
